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Abstract: 
 
Context: Homozygous mutations within LEPR, the leptin receptor (OB-R) gene, are rare and cause early-
onset obesity. The genomic organization of the LEPR gene is complex and generates three independent 
transcripts whose respective functions are still poorly understood. 
Methods/Results: We describe here a 7-year old patient with a homozygous 80 kb deletion in the 
chromosomal 1p31.3 region with early onset obesity, mental retardation and epilepsy. The deleted region 
comprises the proximal promoter and exons 1 and 2 of the LEPR gene and exons 5 to 19 of the DNAJ6C 
gene. The deletion leads to the deficiency of all canonical OB-R isoforms but maintains the B219 OB-R 
short isoforms controlled by the preserved second LEPR promoter. The DNAJ6C gene encodes auxilin-1, 
a protein required for clathrin-dependent recycling of synaptic vesicles in neurons that is possibly at the 
origin of the mental retardation and epilepsy phenotype. The obese phenotype and the absence of 
signaling-competent OB-R are consistent with previously reported individuals with OB-R deficiency. The 
deletion eliminates an additional transcript of the LEPR gene that encodes endospanin-1, a protein that 
has been genetically and biochemically linked to OB-R function. Conclusions: Our study confirms the 
phenotype of individuals with OB-R deficiency and postulates for the first time the effects of auxilin-1 
deficiency (mental retardation/epilepsy) and endospanin-1 deficiency (OB-R specific functions) in 
humans. 
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Introduction  
Obesity is one of the greatest current public health challenges, not only in industrialized countries but also 
in developing countries (1). The obesity epidemic is driven by recent lifestyle and environmental changes 
together with the genetic heritage of each individual. Leptin has been identified as a key hormone of body 
weight regulation and energy homeostasis that acts on leptin receptors (OB-R) that are primarily 
expressed in the hypothalamus but also in other central and peripheral regions (2). The central role of 
leptin and its receptor is illustrated by the obese phenotype of rodents and humans carrying non-
functional mutations in the ob and LEPR genes encoding leptin and its receptor, respectively (3, 4). To 
date, only 10 families have been reported with mutations in the LEPR gene (5-7). Homozygous carriers of 
these mutations show early onset obesity, hyperphagia, altered immune function and hypogonadotropic 
hypergonadism with the lack of pubertal growth spurt. 
The genomic organization of the LEPR gene is complex. The P1 promoter of the LEPR gene generates 
two distinct transcripts through alternative splicing, the OB-R transcript and the Leptin Receptor 
Overlapping Transcript (LEPROT) that share the same 5’ untranslated region but use different AUG 
initiation codons giving rise to two distinct open reading frames (Fig. 1A) (8, 9). The OB-R transcript 
encodes different OB-R protein isoforms including the signaling-competent long OB-Rb isoform. The 
LEPROT transcript encodes OB-R gene-related protein (OB-RGRP) or also called endospanin-1, which 
has no sequence homology with OB-R (8). Furthermore, OB-R/B219, a third transcript, is expressed from 
a second, internal, P2 promoter (Fig. 1A). This transcript generates different short OB-R isoforms (B219), 
with an expression pattern that is different from the receptors originating from the OB-R transcript 
(giving rise to long and short isoforms). Despite earlier suggestions that OB-R isoforms generated by the 
OB-R/B219 transcript might be involved in hematopoiesis (10), their function remains still largely 
unknown.  
Recently it has been shown that Endospanin-1 regulates the number of OB-R at the cell surface in vitro by 
retaining the receptor in intracellular compartments through an interaction with OB-R (9, 11). The 
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phenotype of knockout mice for endospanin-1 has not been described so far. Interestingly, shRNA-
mediated silencing of endospanin-1 specifically in the hypothalamic arcuate nucleus improves OB-R-
dependent signaling and prevents against the development of diet-induced obesity (11).  
We describe here the phenotype of a 7-year-old boy carrying a homozygous deletion of a 80 kb region at 
chromosomal 1p31.3 region that includes most of the coding exons of DNAJ6C gene and the 5’ part of 
the LEPR gene resulting in the abolishment of auxilin-1, OB-R and LEPROT transcripts but the 
maintenance of the OB-R/B219 transcript. 
 
Case History And Clinical Examination 
In 2004, a 3 year old male patient with early severe obesity was referred to the Genetic Counseling Unit, 
Vannes, France, to investigate his obesity-associated hyperphagia and developmental delay (fine motor 
problems associated with language learning difficulties). By 7 years old, he was 122cm tall and weighed 
41 kg, with a BMI of 27.5 kg/m2 thus above the 99th percentile defining a state of obesity (Fig. 1B-D). 
The patient was born with a birth weight of 4090g, which is at the upper limit of normal birth weight (Fig. 
1B). Starting from the age of 1, the BMI of the patient was higher than normal, mainly due to increased 
body weight (Fig. 1C) associated with elevated food-seeking behavior.  
Clinical examinations of the patient (III1) showed normal height evolution until the age of 11 years. He 
exhibited mild dysmorphic features (round face, mild brachydactyly, undescended testis), obesity, mental 
retardation and epilepsy, but with no other clinical abnormalities. Past family history revealed that most 
members were overweight or obese (Fig. 1E, Table 1) and the patient’s maternal grandmother (I2) as well 
as two paternal aunts (II1, II2) showed an epileptic history. The two latter (II1, II2) exhibited also mild 
mental retardation. However, in the present study, we were unable to further explore individuals from the 
paternal family. 
The patient showed normal levels of serum lipids and hormones (Table 2). The number of blood cells was 
normal with the exception of low CD4+ T lymphocytes and increased CD8+ T lymphocytes that results in 
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a low CD4/CD8 T-cell ratio. The number NK lymphocytes was higher than normal (Fig. 2A). A summary 
of the features of mental retardation and the epileptic syndrome of III1 are presented in Supplementary 
table 1. 
 
Materials and Methods 
 
Blood parameters 
Plasma levels of hormones and lipids were determined by standard methods and immunophenotyping 
by flow cytometry with a FACS Calibur (BECTON –DICKINSON). 
 
Array-CGH 
Oligonucleotide array-CGH was performed using the Agilent Human Genome CGH microarray 44K 
(Agilent Technologies, Santa Clara, CA, USA). These microarrays comprise more than 44,000 60-mer 
oligonucleotide probes that span both coding and non-coding regions. Microarrays were scanned using 
the Agilent scanner G2565BA. Data were analyzed with Agilent DNA Analytics software to identify 
chromosome aberrations. Identification of probes with a significant gain or loss was based on the log2 
ratio plot deviation from 0 with cut-off values of 0.5 to 1 or -0.5 to -1 respectively. A value of -4 
characterise a homozygous deletion. 
 
Multiplex PCR/Liquid chromatography (MP-LC) 
Duplex PCR was performed, associating unlabeled primers for an endogenous control gene, HMBS, 
and for OB-R/LEPR showing imbalance in the patient. Duplex for normal control, patient and parents 
gDNAs was performed as described elsewhere (12, 13). Data analysis was performed using the 
Navigator™ Software (Transgenomic, Omaha, NE, USA), normalisation was achieved with HMBS peak 
and relative peak intensities directly reflected OB-R/LEPR genomic copy number. 
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DNA extraction, RNA extraction and semi quantitative RT-PCR 
DNA and RNA extractions and RT-PCR experiments were performed according to standard 
procedures (for primers see supplementary table 2). 
 
Results 
 
Blood chromosome analysis showed that the subject (III1) had a normal karyotype. Initial genetic tests 
excluded X Fragile Syndrome, the most common inherited cause of intellectual disability associated in 
some cases with obesity in males. Genetic tests on paternal chromosome 15q11-q13 as well as III1 
clinical features (no hypotonia, no genital hypoplasia, no short stature) excluded Prader-Willi syndrome 
which is a complex genetic condition also characterized with obesity and intellectual impairment (data not 
shown). Array-CGH analysis revealed a chromosome 1 interstitial homozygous deletion on 1p31.3, 
confirmed by dye-swap (Fig. 1F) and excluded any other micro-deletion in the genome. The distal 
breakpoint mapped within the chromosome interval 65.604 Mb (the last non deleted probe) and 65.627 
Mb (deletion starting point) from 1p telomere and the proximal one within the chromosome interval 
65.707 (deletion ending point) and 65.744 Mb (first non deleted probe). Hence the deletion encompasses 
about 80 kilobases. To confirm array data, multiplex PCR/Liquid Chromatography (MPLC) experiments 
were performed for III1 and his parents. The homozygous deletion was confirmed in III1, inherited from 
asymptomatic and probably consanguineous parents, as each were heterozygous for the same deletion 
(Fig. 1G). The 80 kilobases deletion comprises only two known genes: (i) the DNAJ6C gene, encoding 
auxilin-1, a protein predominantly expressed in the brain that is required for clathrin recycling in cells 
(14), and (ii) the LEPR gene, known to encode the leptin receptor (OB-R) (15) and endospanin-1 (8, 9). 
The deletion encompasses the 3’ region of the DNAJ6C gene starting from DNAJ6C exon 5 and includes 
the 5’ part of the LEPR gene comprising the proximal P1 promoter region and exons 1 and 2 (Fig. 1A, 
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1F). MPLC analysis showed that both parents are heterozygous for the 1p31.3 deletion (Fig. 1G) and that 
6 other related family members exhibited the same 1p31.3 deletion (Fig. 1E, 1G).  
To further confirm the absence of the 1p31.3 region in III1, specific PCR primers were designed to 
amplify this region in III1 and other family members (Fig. 1A, Supplementary Fig. 1A). As expected, 
primers specific for DNAJ6C gene exon 9 and for LEPR gene exon 2 readily revealed the expected 
amplicon in heterozygous family members but not in III1.  
The deletion of 91% of DNA6JC coding region is in accordance with the absence of functional auxilin-1 
transcript in III1 as compared to wild type or heterozygous carriers (Fig. 2B). 
The presence of LEPR gene exon 8 was detected in all cases consistent with the partial deletion of the 
LEPR gene. The corresponding mRNAs for auxilin-1, LEPROT and OB-R were absent in blood samples 
of III1 but present in heterozygous family members (Fig. 2B). Similar results were obtained in skin 
mRNA preparations (Supplementary Fig. 1B).  
The presence of OB-R/B219 transcript generated from the internal P2 promoter was confirmed in mRNA 
samples prepared from III1 blood cells (Fig. 2B). Expression in blood cells but not in skin cells (data not 
shown) is in accordance with previous reports (8, 10).  
Endospanin-1 has a unique homologue in the human genome called endospanin-2 that is encoded by the 
LEPROTL1 gene located on chromosome 8p21.1-8p21.2 (9, 16). As recent studies in transfected cells 
suggest that both endospanins negatively regulate OB-R surface expression, a compensatory effect of one 
endospanin in the absence of the other might be possible. However, semi-quantitative RT-PCR analysis 
showed that similar amounts of endospanin-2 mRNA were present in blood samples of III1, heterozygous 
carriers and wild-type family members (Supplementary Fig. 1C, Fig. 2C).  
 
Discussion 
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In the present study, we report for the first time a patient (III1) with a homozygous deletion within the 
chromosomal 1p31.3 region comprising only two predicted genes, DNAJ6C and LEPR genes. Whereas 
III1 with the homozygous deletion showed early on-set obesity, mental retardation and epilepsy, 8 
heterozygous carriers including a sibling of III1 are also overweight or obese, but do not exhibit mental 
retardation or epilepsy (except 1 member).  
 
DNAJ6C encodes auxilin-1, a protein expressed in the brain and acting as a co-chaperone to support 
Hsc70-dependent clathrin uncoating of clathrin-coated vesicles in neurons (14). Mice with targeted 
deletion of auxilin-1 show recycling and endocytosis defects of synaptic vesicles and are characterized by 
early postnatal mortality likely due to neurological and cognitive impairment (17). Recently, major 
reports demonstrated that, in mice and humans, deficiency of genes involved in synaptic vesicle recycling 
and endocytosis lead to impairment of neurocognitive functions characterized by mental retardation, 
defect in learning/memory and seizures: endophilin (18), oligophrenin-1 (19-21), dynamin-1 (22), 
amphiphysin-1 (23), synaptojanin-1 (24, 25). Importantly, given the widespread impact of synaptic 
neurotransmission on brain functions, many of these deficiencies led to perinatal mortality due to severe 
neurologic defects (17, 18, 23-25). We propose that auxilin-1 could be a new potential candidate gene for 
mental retardation and/or seizure, which requires further investigation in other human genetic studies. 
 
Deletion of exons 1-2 and of P1 promoter of LEPR gene eliminates OB-R and LEPROT transcripts but 
not the OB-R/B219 transcript, which uses the internal P2 promoter. The phenotype of previously reported 
patients with non-functional OB-R resembles that of III1 described in our study: early onset obesity, 
hyperphagia and modification of the immune cells. Moreover, the high circulating leptin level of 50 
ng/mL in the patient (normal range for boys of similar age is below 11.2 ng/mL), may explained the 
absence of a putative negative feedback loop between leptin signaling and leptin secretion. Consistently, 
decreased CD4/CD8 T lymphocyte ratios have also been observed in humans with congenital leptin 
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deficiency (26). The lack of pubertal growth spurt and hypogonadotropic hypergonadism reported for 
patients with leptin or OB-R deficiency has not yet been observed, as III1 is too young. Thus, obesity and 
defects in immune cells observed in III1 are most likely explained by the absence of the signaling-
competent long OB-Rb isoform. Mental retardation and epilepsy are unlikely to be causally related to the 
absence of OB-Rb as other reported mutations of the leptin pathway do not present this phenotype.  
Whereas previously described mutations of the LEPR gene concern all OB-R and OB-R/B219 transcripts 
equally, deletion of LEPR gene exons 1 and 2, identified in our study, only abolishes OB-Ra/b transcript 
leaving the OB-R/B219 transcripts fully functional. Interestingly, the obese phenotype and the modified 
CD4+/CD8+ T-cell ratio observed in III1 supports the idea that OB-R/B219 transcripts are not likely to 
be involved in these functions.  
 
Some complex pleiotropic syndromes in which obesity is only one of the clinical phenotype of 
developmental anomalies are largely described (27). Many of the clinical phenotypes characterizing these 
syndromes were not seen in III1 and his family. Moreover, genetic analysis did not confirm the presence 
of X Fragile syndrome and Prader-Willi syndrome in III1. Human deficiency of BDNF (28) or of its 
cognate receptor TrkB (29) was also shown to trigger severe obesity, intellectual abilities and seizures. 
However, III1 does not likely have such mutations since BDNF or TrkB subjects also developed 
hyperactivity, impairment of nociception, hypotonia which were not observed in III1. 
 
This is the first study reporting the homozygous deletion of the LEPROT transcript of the LEPR gene. No 
other mutations have been reported so far for this transcript in humans. Endospanin-1, the corresponding 
protein of the LEPROT transcript, has been recently shown to regulate OB-R function (9, 11). However, 
due to the simultaneous absence of the signaling-competent OB-Rb isoform in III1, we are unable to 
confirm this prediction. Normal IGF1 levels and normal growth of III1 also excludes any OB-R-
independent effects on these parameters as suspected from a transgenic mouse model over-expressing 
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endospanin-1 (30). Our study allows us to postulate a preliminary phenotype of endospanin-1 deficiency 
in humans. As the phenotype of III1 is likely to be dominated by the absence of auxilin-1 (mental 
retardation, epilepsy) and OB-Rb (early on-set obesity, modified immune cell composition), it is likely 
that the absence of endospanin-1 has no major phenotypic consequences in humans in the context of OB-
Rb deficiency. Co-evolution of both transcripts under the control of the same promoter further supports 
this conclusion.  
 
In conclusion, we describe here a unique homozygous 80 kb deletion in the chromosomal 1p31.3 region 
that confirms the early onset obesity of individuals with OB-R deficiency and suggests for the first time 
the phenotype of auxilin-1 and endospanin-1 deficiency in humans. 
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Figure legends 
Figure 1. Deletion of chromosomal 1p31.3 region comprising the DNAJ6C and LEPR gene. A. 
Organization of DNAJ6C and LEPR genes and corresponding transcripts. LEPR gene expression is 
controlled by a dual promoter: the P1 promoter generates two distinct transcripts (Leptin Receptor 
Overlapping Transcript (LEPROT) and OB-R) through alternative splicing giving rise to two distinct 
proteins without any amino acid sequence homology (OB-RGRP/endospanin-1 or OB-R short and long 
isoforms, respectively) and the alternative P2 promoter allows the expression of B219 OBR short 
isoforms. Positions of primers used for genomic DNA (dark grey arrows) and mRNA (soft grey arrows) 
amplification and AUG allowing protein translation are indicated. B-D. Patient’s height (B), body weight 
(C) and Body Mass Index (BMI) (D) from age 1 to age 10. According to the definition of childhood 
obesity in France, 97th and 99th percentile BMI cutoff points characterize moderate and severe obesity 
respectively (equivalent to threshold defining childhood “overweight” or “obesity” according to the 
International Obesity task Force (IOTF) respectively). E. Pedigree chart of the consanguineous family. 
The squares represent male family members and the circles female family members; open symbols 
represent wild type family members and solid symbols are members with deleted allele (grey for 
heterozygous; black for homozygous). F. The patient’s Array-CGH data. The left part of the figure 
shows chromosome 1 ideogram. Each dot represents a single probe spotted on the array. Dots with a 
value of zero represent equal fluorescence intensity ratio between patient sample and reference genomic 
DNAs. Copy number losses shift the ratio to the left or to the right according to the fluorescent labelling. 
The deletion revealed by array-CGH is highlighted (black rectangle) and dye reversal hybridization 
experiment shows a mirror image. The right part of the figure, with the log2 ratio of chromosome 1 
probes, zooms in on this micro-rearrangement and shows which genes are contained in the deletion. G. 
Multiplex PCR/Liquid Chromatography validation experiment. The electrophoregrams of the patient 
(in red) and of the parents (mother in green, father in blue) were superimposed to those of controls (in 
15 
 
black) and normalized on HMBS internal control peak (132 bp) intensity. The presence of a heterozygous 
or homozygous deletion was indicated by a twofold reduction in the height of OB-R/LEPR amplicon peak 
(118 bp) or by a flat profile respectively.  
 
Figure 2: Characterization of gene expression in 5 family members. A.T, B and NK cell population 
counts (absolute values in giga cells/L). B. Semi-quantitative RT-PCR from mRNA extracted from blood 
cells. C. Quantification of endospanin2 mRNA level from Supplem Fig. 1C with ImageJ. GAPDH and 
HPRT genes are used as internal control. * indicates out of normal range. 
 
Table 1: General phenotype of the family members including age, genotype, height, body weight 
(BW), BMI and other diseases. values§ to be compared to normal range of childhood BMI which are age-
dependant in children (see Fig. 1D). 
 
Table 2: Metabolic and endocrine features of 4 family members including the patient (III1) and its 
2 sisters. Age and sex-specific normal ranges for leptin 2.4-11.2 ng/mL for 3-11 years old, <14.8 for 
women, <7.4 for men; for estradiol, < 0.076 pmol/L for clinically prepubertal persons, 0.01-0.75 for 
women in follicular phase; for testosterone, <1.43 ng/mL for clinically prepubertal persons; for Insulin-
like Growth factor 1 (IGF-1), 6-39 for < 10 years old, 15-130 for 10-13 years old, 10-51 for > 13 years 
old; for Follicle-Stimulating hormone (FSH), <1U/L for clinically prepubertal subjects, 1-18 for pubertal 
subjects; for Luteiizing Hormone (LH) < 1U/L for clinically prepubertal subjects, 1.5-13 for pubertal 
subjects. * indicates out of normal range. 
 
Supplementary figure 1: A. PCR on genomic DNA extracted from blood cells. B. Semi-quantitative RT-
PCR from mRNA extracted from skin biopsies. C. Semi-quantitative RT-PCR from mRNA extracted 
from blood cells 
Vauthier et al. Figure 1 
Vauthier et al. Figure 2 
Vauthier et al. 
Vauthier et al. 
Vauthier et al. Supplementary Figure 1 
Age Development Epilepsy 
month 3 Head held up 
Hyperthermic seizures month 6 
month 9 Sits unsupported 
month 20 Walks with support Hyperthermic seizures 
year  2.5 Walks alone but unstable, 
 No language 
1 Grand Mal Seizure 
year  3.5 Climbing stairs by crawling,  
unable  to jump 
1 Grand Mal Seizure 
Epileptic encephalopathy with diffuse  
slow spike-waves 
year  5 Poor language, unstable walk 
year  6 3 short seizures (<15 minutes) 
year  8 Tonic-clonic seizures (45 minutes) 
year  9 Tonic-clonic seizures (30 minutes) 
year  10 IQ = 40 2 Tonic-clonic seizures (>2hours) and (3 hours) 
Vauthier et al. 
Supplementary Table 1: Clinical survey: Motor and speech disabilities and epilepsy  
 
Vauthier et al. 
Primers Sequences Gene 
Genomic DNA 
DNAJ6C 5’-GTTTACCCTTATTCCCTCAC-3’ 
5’-AGTTTGTTTTAGCCAGCAGT-3’ 
LEPR 5’-GGACAACCAGCCAAAGGAC-3’ 
5’-CAGGTGAGGGGCAAGAGACT-3’ 
GAPDH 5’-GATGGCATGGACTGTGG-3’ 
5’-CCCGCTCCCTCTTTCTTTG-3’ 
5’-TCAGAAATCGGAGAAGTCAT-3’ Auxilin-1 
Transcripts 
5’-AGAGGTGGAGGTGGCAGAGC-3’ 
OB-R 5’-AGCAGCCGCGGCCCCAGTTC-3’ 
5’-TGACAAGTTAAACGCAGTTATCACAT-3’ 
LEPROT 5’-GAGGAGGGGCTACCACTGTTC-3’ 
5’-GGGCTGACTTTTCTTATGCT-3’ 
HPRT 5’-AGGACCTCTCGAAGTGT-3’ 
5’-ATTCAAATCCCTGAAGTACTCAT-3’ 
GAPDH 5’-GATGGCATGGACTGTGG-3’ 
5’-GGAGAAGGCTGGGGC-3’ 
5’-TGACAAGTTAAACGCAGTTATCACAT-3’ 
5’-AGCAGCCGCGGCCCCAGTTC-3’ 
OB-R/B219 
Supplementary Table 2: Primer sequences 
 
